New American Prophet (N.A.P.) | The Website for Insight
On Tuesday, news broke that the National Institutes of Health (NIH) funded a study on mostly minors who purported to identify as transgender, in which they were given cross-sex hormones over the course of two years. Two of the study’s participants ended up committing suicide, and 11 more experienced suicidal ideation. Lawmakers and doctors are expressing outrage that taxpayer dollars were used to fund a study that caused death and irreversible harm to children.
The study, entitled “Psychosocial Functioning in Transgender Youth after 2 Years of Hormones,” was published in The New England Journal of Medicine in January and was conducted by the Boston Children’s Hospital, the University of California at San Francisco, and the Lurie Children’s Hospital of Chicago under a $477,444 five-year grant from NIH. It studied 315 participants aged 12-20 who identified as transgender or nonbinary, 240 of which were minors.
Each participant was given cross-sex hormones over the course of the two-year study, meaning that they were given hormones of the opposite biological sex in order to appear more like the opposite sex. Despite claiming that “appearance congruence, positive affect, and life satisfaction increased, and depression and anxiety symptoms decreased” among the participants, the study went on to acknowledge that two people died by suicide and 11 people experienced “suicidal ideation” (“a broad term used to describe a range of contemplations, wishes, and preoccupations with death and suicide”).
“It is sickening that the federal government is preying on young people and using our taxpayer dollars to advance its radical gender ideology,” Rep. Josh Brecheen (R-Okla.) told The Daily Signal. “We are rightfully demanding answers from NIH, and we are committed to holding those responsible accountable for this tragic loss of life.” Brecheen is one of 15 Republican lawmakers that signed a letter to NIH Acting Director Lawrence Tabak expressing “grave concerns” over the study…
